Leading Pharmaceutical Company Turns to Dendrite’s Complete Sample and Compliance Solution; Outsourcing Services to Dendrite’s BuzzeoPDMA Division Enables Company to Reduce Overall Regulatory Costs and Improve Compliance Effectiveness
Dendrite International, Inc. a leading provider of sales, marketing, clinical and compliance solutions for the life sciences industry, today announced a comprehensive, three-year agreement with a US-based division of a leading European pharmaceutical company seeking to reduce costs and increase effectiveness of its sample execution and compliance management. The Dendrite compliance solutions include complete outsourcing of the sample management lifecycle, plus consulting and auditing to comply with the policies of the Food and Drug Administration (FDA) and the Prescription Drug Marketing Act (PDMA).
With the increasing pressure to comply with government-mandated regulations, pharmaceutical and life science companies are realizing the need to make investments into properly managing their sampling and compliance programs. The proper management of these programs is emerging as an increasingly critical component of a pharmaceutical product’s success, and the infrastructure to manage these processes and regulations are becoming increasingly expensive and burdensome.
The Dendrite solution, managed by its BuzzeoPDMA division, is to execute all components of the company’s sample management and compliance process, including establishing standard operating procedures; auditing and inventory services; distribution and fulfillment; document scanning and data capture; PDMA consulting; and reconciliation services.
“There is real value in outsourcing sample accountability and PDMA compliance programs since it has proven to be a cost-effective business model for pharmaceutical and life sciences companies,” said Bill Buzzeo, vice president, Dendrite BuzzeoPDMA. “Our resident experts keep abreast of industry issues to provide our customers with the most advanced and intuitive sample accountability and compliance solutions available.”
About Dendrite
Founded in 1986, Dendrite International, Inc.,(NASDAQ: DRTE) provides award-winning sales, marketing, clinical and compliance solutions and services to global pharmaceutical and other life sciences companies. With clients in more than 50 countries, including the world’s top 20 pharmaceutical companies, Dendrite strives to be the first source for expert promotional and sales effectiveness solutions. For more information, please visit www.dendrite.com .
Note: Dendrite is a registered trademark of Dendrite International, Inc.
